Pharma Is the New Tech: The Future of AI in Life Sciences

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Pharma Is the New Tech: The Future of AI in Life Sciences

Listen for free

View show details

About this listen

AI is transforming drug discovery and clinical trials, making what was once cutting-edge the new standard. Pharma companies are evolving into tech companies, leveraging AI to revolutionize every phase of drug development.

In this episode, Chris McSpiritt, VP of Life Sciences Strategy at Domino, discusses how AI is no longer a niche capability for select firms but an essential capability for all biopharma organizations. We explore AI-based digital organisms, the increasing reliance on AI in clinical trials, and the shift toward personalized medicine.

Join us as we dive into:

How AI will drive the majority of new drug discoveries
The role of AI in clinical trials
The growing need for pharma companies to adopt a tech company mindset
The impact of AI-driven automation on regulatory compliance and reporting

No reviews yet